These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22009087)

  • 1. Advocates call for FDA to take tougher stance on postmarket safety studies.
    Kuehn BM
    JAMA; 2011 Oct; 306(15):1639-40, 1642. PubMed ID: 22009087
    [No Abstract]   [Full Text] [Related]  

  • 2. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
    Rathi VK; Krumholz HM; Masoudi FA; Ross JS
    JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silicone breast implants may be close to US approval.
    Ault A
    Lancet; 2003 Oct; 362(9393):1384. PubMed ID: 14594002
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA demands more information about breast implants.
    Ault A
    Lancet; 2004 Jan; 363(9404):218. PubMed ID: 14746317
    [No Abstract]   [Full Text] [Related]  

  • 6. Postmarket surveillance. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jun; 67(109):38878-92. PubMed ID: 12053947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US and European postmarket clinical data requirements.
    Donawa M
    Med Device Technol; 2005 Mar; 16(2):19-21. PubMed ID: 15828495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revised draft guidance document for breast implants.
    FDA Consum; 2004; 38(2):4. PubMed ID: 15101353
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10640-1. PubMed ID: 10177505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of the FDA in Ensuring the Safety and Efficacy of Artificial Intelligence Software and Devices.
    Allen B
    J Am Coll Radiol; 2019 Feb; 16(2):208-210. PubMed ID: 30389329
    [No Abstract]   [Full Text] [Related]  

  • 11. US Congress considers new tracking system for medical devices after excessive recalls.
    Epstein K
    BMJ; 2012 Apr; 344():e2915. PubMed ID: 22529316
    [No Abstract]   [Full Text] [Related]  

  • 12. The evolution of FDA policy on silicone breast implants: a case study of politics, bureaucracy, and business in the process of decision-making.
    Palley HA
    Int J Health Serv; 1995; 25(4):573-91. PubMed ID: 8575864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Junk science" in the courtroom. Causes and effects.
    Price JM; Gates GS
    ASAIO J; 1995; 41(2):139-42. PubMed ID: 7640415
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical devices; medical device user facility and manufacturer reporting, certification and registration; Office of Management and Budget approval; extension of effective date--FDA. Final rule; notification of approval of information collection requirements.
    Fed Regist; 1996 Apr; 61(71):16043-5. PubMed ID: 10157704
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical device regulation: an introduction for the practicing physician.
    Maisel WH
    Ann Intern Med; 2004 Feb; 140(4):296-302. PubMed ID: 14970153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descriptive analysis of postmarket surveillance data for hip implants.
    Pane J; Verhamme KMC; Rebollo I; Sturkenboom MCJM
    Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):380-387. PubMed ID: 32128913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New technology in electrophysiology: FDA process and perspective.
    Selzman KA; Fellman M; Farb A; de Del Castillo S; Zuckerman B
    J Interv Card Electrophysiol; 2016 Oct; 47(1):11-18. PubMed ID: 27020440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IOM advises FDA on ethics in postmarket safety trials.
    Kuehn BM
    JAMA; 2010 Aug; 304(6):627. PubMed ID: 20699450
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA pilot programme in support of global harmonisation.
    Donawa ME
    Med Device Technol; 2003 Nov; 14(9):32-4. PubMed ID: 14682021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [United States Medical Device Postmarket Surveillance System Operational Experience and Learning].
    Zhu S; Xu X
    Zhongguo Yi Liao Qi Xie Za Zhi; 2017 Mar; 41(2):123-126. PubMed ID: 29862685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.